Catalyst Pharmaceutical Partners Inc buy Cantor Fitzgerald
Start price
01.03.24
/
50%
€16.00
Target price
01.03.25
€31.37
Performance (%)
-4.72%
Price
14.05.24
€15.25
Summary
This prediction is currently active. With a performance of -4.72%, the BUY prediction by Cantor_Fitzgerald is trending in the wrong direction. This prediction currently runs until 01.03.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Catalyst Pharmaceutical Partners Inc | 8.274% | 8.274% |
iShares Core DAX® | 1.662% | 4.835% |
iShares Nasdaq 100 | 0.667% | 0.000% |
iShares Nikkei 225® | -2.139% | -4.786% |
iShares S&P 500 | 0.564% | 0.775% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its price target raised by analysts at Cantor Fitzgerald from $27.00 to $34.00. They now have an "overweight" rating on the stock.
Ratings data for CPRX provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Catalyst Pharmaceutical Partners Inc
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€14.55
22.03.24
22.03.24
€31.46
22.03.25
22.03.25
4.78%
14.05.24
14.05.24